References
- Maisels MJ, Kring E. The contribution of hemolysis to early jaundice in normal newborns. Pediatrics 2006;118:276–279.
- Cashore WJ. Bilirubin and jaundice in the micropremie. Clin Perinatol 2000;27:171–179, vii.
- Hillman N. Hyperbilirubinemia in the late preterm infant. Newborn Infant Nurs Rev 2007;7:91–94.
- Isolauri E. Probiotics in human disease. Am J Clin Nutr 2001;73:1142S–1146S.
- Husebye E, Hellström PM, Sundler F, Chen J, Midtvedt T. Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats. Am J Physiol Gastrointest Liver Physiol 2001;280:G368–G380.
- Banasaz M, Norin E, Holma R, Midtvedt T. Increased enterocyte production in gnotobiotic rats mono-associated with Lactobacillus rhamnosus GG. Appl Environ Microbiol 2002;68:3031–3034.
- van Meer H, Boehm G, Stellaard F, Vriesema A, Knol J, Havinga R, Sauer PJ, Verkade HJ. Prebiotic oligosaccharides and the enterohepatic circulation of bile salts in rats. Am J Physiol Gastrointest Liver Physiol 2008;294:G540–G547.
- Floch MH. Bile salts, intestinal microflora and enterohepatic circulation. Dig Liver Dis 2002;34 Suppl 2:S54–S57.
- Usman, Hosono A. Effect of administration of Lactobacillus gasseri on serum lipids and fecal steroids in hypercholesterolemic rats. J Dairy Sci 2000;83:1705–11.
- Kurugöl Z, Koturoglu G. Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr 2005;94:44–47.
- Dinleyici EC, Eren M, Yargic ZA, Dogan N, Vandenplas Y. Clinical efficacy of Saccharomyces boulardii and metronidazole compared to metronidazole alone in children with acute bloody diarrhea caused by amebiasis: a prospective, randomized, open label study. Am J Trop Med Hyg 2009;80:953–955.
- Turkish Neonatal Society. Neonatal indirect hyperbilirubinemia. Turkish Neonatal Society Bulletin 2002;6:12–19.
- Hansen TW. Recent advances in the pharmacotherapy for hyperbilirubinaemia in the neonate. Expert Opin Pharmacother 2003;4:1939–1948.
- Odell GB, Gutcher GR, Whitington PF, Yang G. Enteral administration of agar as an effective adjunct to phototherapy of neonatal hyperbilirubinemia. Pediatr Res 1983;17:810–814.
- Caglayan S, Candemir H, Aksit S, Kansoy S, Asik S, Yaprak I. Superiority of oral agar and phototherapy combination in the treatment of neonatal hyperbilirubinemia. Pediatrics 1993;92:86–89.
- Davis DR, Yeary RA, Lee K. Activated charcoal decreases plasma bilirubin levels in the hyperbilirubinemic rat. Pediatr Res 1983;17:208–209.
- Nishioka T, Hafkamp AM, Havinga R, vn Lierop PP, Velvis H, Verkade HJ. Orlistat treatment increases fecal bilirubin excretion and decreases plasma bilirubin concentrations in hyperbilirubinemic Gunn rats. J Pediatr 2003;143:327–334.
- Nicoll A, Ginsburg R, Tripp JH. Supplementary feeding and jaundice in newborns. Acta Paediatr Scand 1982;71:759–761.
- Gartner LM. Neonatal jaundice. Pediatr Rev 1994;15:422–432.
- Hansen TW. Acute management of extreme neonatal jaundice–the potential benefits of intensified phototherapy and interruption of enterohepatic bilirubin circulation. Acta Paediatr 1997;86:843–846.
- Gupta V, Garg R. Probiotics. Indian J Med Microbiol 2009;27:202–209.
- Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003;361:512–519.
- van den Broek P, Verkade HJ, Hulzebos CV. Hyperbilirubinemia in infants with Gram-negative sepsis does not affect mortality. Early Hum Dev 2011;87:515–519.